Developing new treatments for Alzheimer's disease
Structural Biology & Biophysics Core (SBB)
This study is all about finding better treatments for Alzheimer's disease by looking closely at certain proteins involved in the condition, so we can create new and more effective medications that could help patients feel better.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-10950442 on NIH RePORTER |
What this research studies
This research focuses on creating high-quality compounds that target Alzheimer's disease by understanding the structure and behavior of specific proteins involved in the disease. The team will use advanced techniques to study how these proteins interact with potential drugs, which will help in designing more effective treatments. By characterizing the biochemical and biophysical properties of these proteins, the research aims to optimize drug candidates for better therapeutic outcomes. Patients may benefit from new therapies developed through this innovative approach.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk of developing it.
Not a fit: Patients with other forms of dementia unrelated to Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective treatments for Alzheimer's disease.
How similar studies have performed: Other research has shown promise in using structural biology approaches to develop treatments for Alzheimer's, indicating a potential for success in this area.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Mesecar, Andrew D — Indiana University Indianapolis
- Study coordinator: Mesecar, Andrew D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.